No Data
BridgeBio Selects PANTHERx Rare Specialty Pharmacy for Distribution of Attruby (Acoramidis)
Mizuho Securities Maintains BridgeBio Pharma(BBIO.US) With Buy Rating
BridgeBio Pharma Receives Buy Rating Following Attruby's FDA Approval and Strategic Milestones
Trending Stocks Today | Ambarella Shoots up 24.58% Post-Market
BridgeBio Stock Up on FDA Approval of Cardiovascular Drug
A Quick Look at Today's Ratings for BridgeBio Pharma(BBIO.US), With a Forecast Between $45 to $55
105069706 : Fifty rides in just one day.
leo1212 : will it?